H2N2V1, PubMed, Curation, bibRecord, 000144

A human CD4+ T cell epitope in the influenza hemagglutinin is cross-reactive to influenza A virus subtypes and to influenza B virus.

Identifieur interne : 000144 ( PubMed/Curation ); précédent : 000143; suivant : 000145

A human CD4+ T cell epitope in the influenza hemagglutinin is cross-reactive to influenza A virus subtypes and to influenza B virus.

Auteurs : Jenny Aurielle B. Babon [États-Unis] ; John Cruz ; Francis A. Ennis ; Liusong Yin ; Masanori Terajima

Source :

Journal of virology [ 1098-5514 ] ; 2012.

RBID : pubmed:22718815

Descripteurs français

English descriptors

Abstract

The hemagglutinin protein (HA) of the influenza virus family is a major antigen for protective immunity. Thus, it is a relevant target for developing vaccines. Here, we describe a human CD4(+) T cell epitope in the influenza virus HA that lies in the fusion peptide of the HA. This epitope is well conserved in all 16 subtypes of the HA protein of influenza A virus and the HA protein of influenza B virus. By stimulating peripheral blood mononuclear cells (PBMCs) from a healthy adult donor with peptides covering the entire HA protein based on the sequence of A/Japan/305/1957 (H2N2), we generated a T cell line specific to this epitope. This CD4(+) T cell line recognizes target cells infected with influenza A virus seasonal H1N1 and H3N2 strains, a reassortant H2N1 strain, the 2009 pandemic H1N1 strain, and influenza B virus in cytotoxicity assays and intracellular-cytokine-staining assays. It also lysed target cells infected with avian H5N1 virus. We screened healthy adult PBMCs for T cell responses specific to this epitope and found individuals who had ex vivo gamma interferon (IFN-γ) responses to the peptide epitope in enzyme-linked immunospot (ELISPOT) assays. Almost all donors who responded to the epitope had the HLA-DRB1*09 allele, a relatively common HLA allele. Although natural infection or standard vaccination may not induce strong T and B cell responses to this highly conserved epitope in the fusion peptide, it may be possible to develop a vaccination strategy to induce these CD4(+) T cells, which are cross-reactive to both influenza A and B viruses.

DOI: 10.1128/JVI.06325-11
PubMed: 22718815

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000144

Links to Exploration step

pubmed:22718815

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A human CD4+ T cell epitope in the influenza hemagglutinin is cross-reactive to influenza A virus subtypes and to influenza B virus.</title>
<author><name sortKey="Babon, Jenny Aurielle B" sort="Babon, Jenny Aurielle B" uniqKey="Babon J" first="Jenny Aurielle B" last="Babon">Jenny Aurielle B. Babon</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Cruz, John" sort="Cruz, John" uniqKey="Cruz J" first="John" last="Cruz">John Cruz</name>
</author>
<author><name sortKey="Ennis, Francis A" sort="Ennis, Francis A" uniqKey="Ennis F" first="Francis A" last="Ennis">Francis A. Ennis</name>
</author>
<author><name sortKey="Yin, Liusong" sort="Yin, Liusong" uniqKey="Yin L" first="Liusong" last="Yin">Liusong Yin</name>
</author>
<author><name sortKey="Terajima, Masanori" sort="Terajima, Masanori" uniqKey="Terajima M" first="Masanori" last="Terajima">Masanori Terajima</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="RBID">pubmed:22718815</idno>
<idno type="pmid">22718815</idno>
<idno type="doi">10.1128/JVI.06325-11</idno>
<idno type="wicri:Area/PubMed/Corpus">000144</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000144</idno>
<idno type="wicri:Area/PubMed/Curation">000144</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000144</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">A human CD4+ T cell epitope in the influenza hemagglutinin is cross-reactive to influenza A virus subtypes and to influenza B virus.</title>
<author><name sortKey="Babon, Jenny Aurielle B" sort="Babon, Jenny Aurielle B" uniqKey="Babon J" first="Jenny Aurielle B" last="Babon">Jenny Aurielle B. Babon</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Cruz, John" sort="Cruz, John" uniqKey="Cruz J" first="John" last="Cruz">John Cruz</name>
</author>
<author><name sortKey="Ennis, Francis A" sort="Ennis, Francis A" uniqKey="Ennis F" first="Francis A" last="Ennis">Francis A. Ennis</name>
</author>
<author><name sortKey="Yin, Liusong" sort="Yin, Liusong" uniqKey="Yin L" first="Liusong" last="Yin">Liusong Yin</name>
</author>
<author><name sortKey="Terajima, Masanori" sort="Terajima, Masanori" uniqKey="Terajima M" first="Masanori" last="Terajima">Masanori Terajima</name>
</author>
</analytic>
<series><title level="j">Journal of virology</title>
<idno type="eISSN">1098-5514</idno>
<imprint><date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antibodies, Viral (immunology)</term>
<term>CD4-Positive T-Lymphocytes (immunology)</term>
<term>Cells, Cultured</term>
<term>Cross Reactions</term>
<term>Epitopes, T-Lymphocyte (genetics)</term>
<term>Epitopes, T-Lymphocyte (immunology)</term>
<term>Hemagglutinin Glycoproteins, Influenza Virus (genetics)</term>
<term>Hemagglutinin Glycoproteins, Influenza Virus (immunology)</term>
<term>Histocompatibility Antigens Class I (genetics)</term>
<term>Histocompatibility Antigens Class I (immunology)</term>
<term>Humans</term>
<term>Influenza A Virus, H1N1 Subtype (genetics)</term>
<term>Influenza A Virus, H1N1 Subtype (immunology)</term>
<term>Influenza A Virus, H2N2 Subtype (genetics)</term>
<term>Influenza A Virus, H2N2 Subtype (immunology)</term>
<term>Influenza A Virus, H3N2 Subtype (genetics)</term>
<term>Influenza A Virus, H3N2 Subtype (immunology)</term>
<term>Influenza A virus (genetics)</term>
<term>Influenza A virus (immunology)</term>
<term>Influenza B virus (genetics)</term>
<term>Influenza B virus (immunology)</term>
<term>Influenza, Human (genetics)</term>
<term>Influenza, Human (immunology)</term>
<term>Influenza, Human (virology)</term>
<term>Leukocytes, Mononuclear (immunology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Agranulocytes (immunologie)</term>
<term>Anticorps antiviraux (immunologie)</term>
<term>Antigènes d'histocompatibilité de classe I (génétique)</term>
<term>Antigènes d'histocompatibilité de classe I (immunologie)</term>
<term>Cellules cultivées</term>
<term>Déterminants antigéniques des lymphocytes T (génétique)</term>
<term>Déterminants antigéniques des lymphocytes T (immunologie)</term>
<term>Glycoprotéine hémagglutinine du virus influenza (génétique)</term>
<term>Glycoprotéine hémagglutinine du virus influenza (immunologie)</term>
<term>Grippe humaine (génétique)</term>
<term>Grippe humaine (immunologie)</term>
<term>Grippe humaine (virologie)</term>
<term>Humains</term>
<term>Lymphocytes T CD4+ (immunologie)</term>
<term>Réactions croisées</term>
<term>Sous-type H1N1 du virus de la grippe A (génétique)</term>
<term>Sous-type H1N1 du virus de la grippe A (immunologie)</term>
<term>Sous-type H2N2 du virus de la grippe A (génétique)</term>
<term>Sous-type H2N2 du virus de la grippe A (immunologie)</term>
<term>Sous-type H3N2 du virus de la grippe A (génétique)</term>
<term>Sous-type H3N2 du virus de la grippe A (immunologie)</term>
<term>Virus de la grippe A (génétique)</term>
<term>Virus de la grippe A (immunologie)</term>
<term>Virus influenza B (génétique)</term>
<term>Virus influenza B (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Epitopes, T-Lymphocyte</term>
<term>Hemagglutinin Glycoproteins, Influenza Virus</term>
<term>Histocompatibility Antigens Class I</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antibodies, Viral</term>
<term>Epitopes, T-Lymphocyte</term>
<term>Hemagglutinin Glycoproteins, Influenza Virus</term>
<term>Histocompatibility Antigens Class I</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term>
<term>Influenza A Virus, H2N2 Subtype</term>
<term>Influenza A Virus, H3N2 Subtype</term>
<term>Influenza A virus</term>
<term>Influenza B virus</term>
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Antigènes d'histocompatibilité de classe I</term>
<term>Déterminants antigéniques des lymphocytes T</term>
<term>Glycoprotéine hémagglutinine du virus influenza</term>
<term>Grippe humaine</term>
<term>Sous-type H1N1 du virus de la grippe A</term>
<term>Sous-type H2N2 du virus de la grippe A</term>
<term>Sous-type H3N2 du virus de la grippe A</term>
<term>Virus de la grippe A</term>
<term>Virus influenza B</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Agranulocytes</term>
<term>Anticorps antiviraux</term>
<term>Antigènes d'histocompatibilité de classe I</term>
<term>Déterminants antigéniques des lymphocytes T</term>
<term>Glycoprotéine hémagglutinine du virus influenza</term>
<term>Grippe humaine</term>
<term>Lymphocytes T CD4+</term>
<term>Sous-type H1N1 du virus de la grippe A</term>
<term>Sous-type H2N2 du virus de la grippe A</term>
<term>Sous-type H3N2 du virus de la grippe A</term>
<term>Virus de la grippe A</term>
<term>Virus influenza B</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>CD4-Positive T-Lymphocytes</term>
<term>Influenza A Virus, H1N1 Subtype</term>
<term>Influenza A Virus, H2N2 Subtype</term>
<term>Influenza A Virus, H3N2 Subtype</term>
<term>Influenza A virus</term>
<term>Influenza B virus</term>
<term>Influenza, Human</term>
<term>Leukocytes, Mononuclear</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Cells, Cultured</term>
<term>Cross Reactions</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Cellules cultivées</term>
<term>Humains</term>
<term>Réactions croisées</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The hemagglutinin protein (HA) of the influenza virus family is a major antigen for protective immunity. Thus, it is a relevant target for developing vaccines. Here, we describe a human CD4(+) T cell epitope in the influenza virus HA that lies in the fusion peptide of the HA. This epitope is well conserved in all 16 subtypes of the HA protein of influenza A virus and the HA protein of influenza B virus. By stimulating peripheral blood mononuclear cells (PBMCs) from a healthy adult donor with peptides covering the entire HA protein based on the sequence of A/Japan/305/1957 (H2N2), we generated a T cell line specific to this epitope. This CD4(+) T cell line recognizes target cells infected with influenza A virus seasonal H1N1 and H3N2 strains, a reassortant H2N1 strain, the 2009 pandemic H1N1 strain, and influenza B virus in cytotoxicity assays and intracellular-cytokine-staining assays. It also lysed target cells infected with avian H5N1 virus. We screened healthy adult PBMCs for T cell responses specific to this epitope and found individuals who had ex vivo gamma interferon (IFN-γ) responses to the peptide epitope in enzyme-linked immunospot (ELISPOT) assays. Almost all donors who responded to the epitope had the HLA-DRB1*09 allele, a relatively common HLA allele. Although natural infection or standard vaccination may not induce strong T and B cell responses to this highly conserved epitope in the fusion peptide, it may be possible to develop a vaccination strategy to induce these CD4(+) T cells, which are cross-reactive to both influenza A and B viruses.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22718815</PMID>
<DateCompleted><Year>2012</Year>
<Month>11</Month>
<Day>05</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>86</Volume>
<Issue>17</Issue>
<PubDate><Year>2012</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Journal of virology</Title>
<ISOAbbreviation>J. Virol.</ISOAbbreviation>
</Journal>
<ArticleTitle>A human CD4+ T cell epitope in the influenza hemagglutinin is cross-reactive to influenza A virus subtypes and to influenza B virus.</ArticleTitle>
<Pagination><MedlinePgn>9233-43</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.06325-11</ELocationID>
<Abstract><AbstractText>The hemagglutinin protein (HA) of the influenza virus family is a major antigen for protective immunity. Thus, it is a relevant target for developing vaccines. Here, we describe a human CD4(+) T cell epitope in the influenza virus HA that lies in the fusion peptide of the HA. This epitope is well conserved in all 16 subtypes of the HA protein of influenza A virus and the HA protein of influenza B virus. By stimulating peripheral blood mononuclear cells (PBMCs) from a healthy adult donor with peptides covering the entire HA protein based on the sequence of A/Japan/305/1957 (H2N2), we generated a T cell line specific to this epitope. This CD4(+) T cell line recognizes target cells infected with influenza A virus seasonal H1N1 and H3N2 strains, a reassortant H2N1 strain, the 2009 pandemic H1N1 strain, and influenza B virus in cytotoxicity assays and intracellular-cytokine-staining assays. It also lysed target cells infected with avian H5N1 virus. We screened healthy adult PBMCs for T cell responses specific to this epitope and found individuals who had ex vivo gamma interferon (IFN-γ) responses to the peptide epitope in enzyme-linked immunospot (ELISPOT) assays. Almost all donors who responded to the epitope had the HLA-DRB1*09 allele, a relatively common HLA allele. Although natural infection or standard vaccination may not induce strong T and B cell responses to this highly conserved epitope in the fusion peptide, it may be possible to develop a vaccination strategy to induce these CD4(+) T cells, which are cross-reactive to both influenza A and B viruses.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Babon</LastName>
<ForeName>Jenny Aurielle B</ForeName>
<Initials>JA</Initials>
<AffiliationInfo><Affiliation>Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Cruz</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Ennis</LastName>
<ForeName>Francis A</ForeName>
<Initials>FA</Initials>
</Author>
<Author ValidYN="Y"><LastName>Yin</LastName>
<ForeName>Liusong</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y"><LastName>Terajima</LastName>
<ForeName>Masanori</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>U19 AI057319</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>U19 AI-057319</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2012</Year>
<Month>06</Month>
<Day>20</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>J Virol</MedlineTA>
<NlmUniqueID>0113724</NlmUniqueID>
<ISSNLinking>0022-538X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018984">Epitopes, T-Lymphocyte</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019267">Hemagglutinin Glycoproteins, Influenza Virus</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015395">Histocompatibility Antigens Class I</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>J Virol. 2013 Aug;87(16):9396</RefSource>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015496" MajorTopicYN="N">CD4-Positive T-Lymphocytes</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003429" MajorTopicYN="N">Cross Reactions</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018984" MajorTopicYN="N">Epitopes, T-Lymphocyte</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019267" MajorTopicYN="N">Hemagglutinin Glycoproteins, Influenza Virus</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015395" MajorTopicYN="N">Histocompatibility Antigens Class I</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053121" MajorTopicYN="N">Influenza A Virus, H2N2 Subtype</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053122" MajorTopicYN="N">Influenza A Virus, H3N2 Subtype</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009980" MajorTopicYN="N">Influenza A virus</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009981" MajorTopicYN="N">Influenza B virus</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007963" MajorTopicYN="N">Leukocytes, Mononuclear</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year>
<Month>6</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2012</Year>
<Month>6</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2012</Year>
<Month>11</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">22718815</ArticleId>
<ArticleId IdType="pii">JVI.06325-11</ArticleId>
<ArticleId IdType="doi">10.1128/JVI.06325-11</ArticleId>
<ArticleId IdType="pmc">PMC3416118</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Protein Pept Lett. 2009;16(7):766-78</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19601906</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2007;2(11):e1190</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18030326</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2002 Dec;76(23):12388-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12414983</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunol Rev. 2006 Jun;211:8-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16824113</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 1995 Jan 15;154(2):703-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7529284</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2011 Aug 12;333(6044):850-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21798894</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Comput Biol. 2008 Apr;4(4):e1000048</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18389056</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Invest. 2010 May;120(5):1663-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20389023</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Microbes Infect. 2008 Jul;10(9):1024-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18662798</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Intern Med. 2011 May;269(5):507-18</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21362069</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunogenetics. 2011 Jun;63(6):325-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21305276</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Influenza Other Respir Viruses. 2010 Sep;4(5):249-58</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20716156</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 1987 Sep;84(17):6234-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3476943</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Med. 2012 Feb;18(2):274-80</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22286307</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2006 Jan 1;193(1):49-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16323131</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2008;3(12):e3942</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19079604</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunology. 2011 Jun;133(2):246-56</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21517839</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2001 Jan 15;166(2):741-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11145645</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 1997 Nov 24;238(2):380-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9400611</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Biol. 2005 Mar;3(3):e91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15760272</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Top Microbiol Immunol. 2001;260:171-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11443873</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2009 Jun 12;27(29):3862-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19446935</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Hum Immunol. 1994 Sep;41(1):28-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7836061</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 1991 Apr 18;350(6319):619-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2017257</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2010 Nov 1;185(9):4998-5002</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20889549</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunology. 1983 Dec;50(4):659-66</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6197356</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Tissue Antigens. 2011 Apr;77(4):329-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21388356</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 1999 Jun 15;162(12):7578-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10358215</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Immunol. 1997 Dec;27(12):3105-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9464794</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Bull World Health Organ. 1959;20(2-3):297-301</Citation>
<ArticleIdList><ArticleId IdType="pubmed">13651915</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1993 Oct;67(10):5962-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8371350</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2010 Mar;48(3):928-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20089763</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2007 Jul;81(14):7608-19</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17507491</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 1986 Dec;83(23):9149-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3466180</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MBio. 2010 May 18;1(1):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20689752</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2009 Apr 10;324(5924):246-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19251591</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 1989 Dec 15;143(12):4098-103</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2480387</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int Immunol. 1997 Jun;9(6):815-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9199964</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2009 Nov 15;183(10):6432-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19841175</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Immunogenet. 2011 Dec;38(6):475-81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21816002</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MMWR Recomm Rep. 2009 Jul 31;58(RR-8):1-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19644442</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Protein Expr Purif. 1999 Feb;15(1):105-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10024477</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Med. 2010 May;16(5):558-64, 1p following 564</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20436484</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 1983 Feb;80(3):840-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6187004</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Hum Immunol. 2009 Sep;70(9):711-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19524006</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2011 Dec;85(24):13310-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21976658</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 1998 Apr 1;160(7):3363-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9531296</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2007 Jul 15;179(2):1303-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17617623</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Annu Rev Biochem. 2000;69:531-69</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10966468</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Front Biosci. 1998 Jul 27;3:d739-45</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9675159</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2008 Nov 11;26(48):6068-76</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19007587</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Struct Mol Biol. 2009 Mar;16(3):265-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19234466</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1995 Dec;69(12):7497-506</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7494256</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunogenetics. 1996;44(5):366-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8781122</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2005 Mar;79(5):2814-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15709000</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2005 Nov 15;175(10):6334-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16272285</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1999 May;73(5):3623-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10196254</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2009 Nov 12;361(20):1945-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19745214</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Hum Immunol. 2000 May;61(5):438-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10773346</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1998 Nov;72(11):8682-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9765409</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Semin Immunol. 2004 Jun;16(3):171-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15130501</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2010 Sep;84(18):9217-26</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20592069</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 1997 Aug 4;234(2):383-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9268170</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2008 Apr 22;105(16):5986-91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18413603</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int Immunol. 1998 Feb;10(2):211-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9533449</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Influenza Other Respir Viruses. 2012 Nov;6(6):389-95</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22236105</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2010 Apr;84(7):3312-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20071564</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2005 Jun 1;174(11):7085-95</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15905552</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2008 Feb 1;180(3):1758-68</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18209073</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Exp Med. 2011 Jan 17;208(1):181-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21220454</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Hum Immunol. 2011 Oct;72(10):872-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21762744</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2006 Sep 1;177(5):2888-98</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16920924</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 1982 Nov 4;300(5887):66-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6982419</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2009 Nov;15(11):1847-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19891882</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1995 Dec;69(12):8046-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7494319</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2005 Jun;79(12):7380-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15919893</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2004 Jul;78(13):7284-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15194806</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Invest. 2008 Oct;118(10):3478-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18802496</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):246-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17200302</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Tissue Antigens. 2010 Jun;75(6):701-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20230525</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2009 Sep 25;27(42):5740-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19660593</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Viral Immunol. 2004;17(2):197-209</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15279699</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2003 Sep 15;171(6):3163-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12960344</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/PubMed/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000144 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000144 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:22718815
   |texte=   A human CD4+ T cell epitope in the influenza hemagglutinin is cross-reactive to influenza A virus subtypes and to influenza B virus.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:22718815" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a H2N2V1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021

	Serveur d'exploration H2N2
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration H2N2

A human CD4+ T cell epitope in the influenza hemagglutinin is cross-reactive to influenza A virus subtypes and to influenza B virus.

A human CD4+ T cell epitope in the influenza hemagglutinin is cross-reactive to influenza A virus subtypes and to influenza B virus.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki